alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Partnerships for Vaccine and Diagnostic Development.                    

*Date:*                         February 20, 2004.                    

*Time:*                         8 a.m. to 6:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Holiday Inn Chevy Chase, 5520 Wisconsin Avenue, Chevy Chase, MD 20815.                    

*Contact Person:*                         Mary J. Homer, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, Room 3255, 6700-B Rockledge Drive, MSC 7616, Bethesda, MD 20892, (301) 496-7042,                         *mjhomer@niaid.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diesases Research, National Institutes of Health, HHS)

Dated: January 28, 2004.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 04-2382 Filed 2-4-04; 8:45 am]

BILLING CODE 4140-01-M
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. 

*Name of Committee:*                         National Institute of Child Health and Human Development Special Emphasis Panel Molecular Bases of Male Infertility.                    

*Date:*                         November 10, 2004.                    

*Time:*                         10 a.m. to 3 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         American Inn of Bethesda, 8130 Wisconsin Avenue, Bethesda, MD 20814.                    

*Contact Person:*                         Jon M. Ranhand, PhD, Scientist Review Administrator, Division of Scientific Review, National Institute of Child                               ( print page 61502)                            Health and Human Development, NIH, 6100 Executive Boulevard, Room 5B01, Bethesda, MD 20892, (301) 435-6884,                         *ranhandj@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS)

Dated: October 12, 2004.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 04-23346  Filed 10-18-04; 8:45 am]

BILLING CODE 4140-01-M
United States Nuclear Regulatory Commission

Office of Public Affairs

Washington, DC 20555

Phone 301-415-8200 Fax 301-415-2234

Internet:opa@nrc.gov

No. 97-153 FOR IMMEDIATE RELEASE

(Thursday, October 9, 1997)

NRC TO HOLD WORKSHOPS ON REVISIONS TO REGULATIONS

ON MEDICAL USES OF RADIOACTIVE MATERIAL

The Nuclear Regulatory Commission will convene public workshops in Philadelphia and

Chicago to obtain comments and recommendations on NRC’s development of revisions to its

regulations on medical uses of licensed radioactive material.

The Philadelphia workshop will be held from 9:00 a.m. to 5:00 p.m. on October 28, from

8:30 a.m. to 5:00 p.m. on October 29, and from 8:30 a.m. to noon on October 30 at the Korman

Suites Hotel, 2001 Hamilton Street.

The Chicago workshop will be held from 9:00 a.m. to 5:00 p.m. on November 12, from

8:30 a.m. to 5:00 p.m. on November 13, and from 8:30 a.m. to noon on November 14 at the

Ramada Congress Hotel, 520 South Michigan Avenue.

The NRC staff has developed alternative approaches for the more significant issues

associated with regulation of medical uses of nuclear material. Specifically, alternative

regulatory text has been developed for (1) the quality management program; (2) training and

experience requirements for authorized users, radiation safety officers and medical physicists;

(3) the radiation safety committee; (4) requirements for notifying patients regarding reportable

events ; and (5) the threshold for reportable events. In addition, alternative recommendations

for revision of NRC’s 1979 medical policy statement have been developed. The staff has not

yet settled on any alternatives and is open to additional alternatives that might be proposed.

The workshop process is not intended to develop a consensus but to elicit comments.

To have a manageable discussion, the number of participants in each workshop must

be limited, but the NRC will attempt to ensure participation by the broad spectrum of interests

that may be affected by the rulemaking. Other members of the public will have the opportunity

to comment at periodic intervals during the workshops. Questions about participation may be

directed to the meeting facilitator, Francis X. Cameron, 301/415-1642.

Copies of the issue papers will be provided to workshop participants and made available

for members of the public at the workshops. They are also available through the NRC Public

Document Room, 2120 L Street, N.W., Washington, D.C. 20555, telephone: 202/637-3273.

They are posted on the Internet at the following address: http://techconf.llnl.gov/noframe.html.

The NRC invites public comments during development of the proposed rule. The

comments should be submitted by March 1 to the Secretary, Nuclear Regulatory Commission,

Washington, D.C. 20555-0001, Attention: Rulemakings and Adjudications Staff.
### §184a. Authorization of States to include in agreements for conservation of oil and gas resources lands acquired from United States

Notwithstanding the provisions of any applicable grant, deed, patent, exchange, or law of the United States, any State owning lands or interests therein acquired by it from the United States may consent to the operation or development of such lands or interests, or any part thereof, under agreements approved by the Secretary of the Interior made jointly or severally with lessees or permittees of lands or mineral deposits of the United States or others, for the purpose of more properly conserving the oil and gas resources within such State. Such agreements may provide for the cooperative or unit operation or development of part or all of any oil or gas pool, field, or area; for the allocation of production and the sharing of proceeds from the whole or any specified part thereof regardless of the particular tract from which production is obtained or proceeds are derived; and, with the consent of the State, for the modification of the terms and provisions of State leases for lands operated and developed thereunder, including the term of years for which said leases were originally granted, to conform said leases to the terms and provisions of such agreements: Provided, That nothing in this section contained, nor the effectuation of it, shall be construed as in any respect waiving, determining or affecting any right, title, or interest, which otherwise may exist in the United States, and that the making of any agreement, as provided in this section, shall not be construed as an admission as to the title or ownership of the lands included.

(Jan. 26, 1940, ch. 14, 54 Stat. 17.)

#### **Editorial Notes**

#### Codification

Section was not enacted as part of act Feb. 25, 1920, ch. 85, 41 Stat. 437, known as the Mineral Leasing Act, which comprises this chapter.
NRC NEWS

UNITED STATES NUCLEAR REGULATORY COMMISSION

OFFICE OF PUBLIC AFFAIRS, REGION II

61 Forsyth Street SW, Atlanta GA 30303

Web Site: www.nrc.gov

No. II-03-052 December 23, 2003

CONTACT: Ken Clark (404)562-4416 E-mail: OPA2@nrc.gov

Roger Hannah (404)562-4417

NRC SENDS AUGMENTED INSPECTION TEAM TO 

ILLINOIS FUEL PLANT AND ISSUES CONFIRMATORY ACTION LETTER

Following a chemical release (uranium hexafluoride) early Monday (December 22) morning at

the Honeywell International nuclear fuel processing plant near Metropolis, Illinois, the Nuclear

Regulatory Commission began dispatching inspectors to the facility. Those inspectors are now part of

a formal group designated as an Augmented Inspection Team or AIT. 

An AIT is formed to review the circumstances surrounding more significant events at NRClicensed facilities. The Honeywell AIT is being led by Jay Henson from the NRC’s Region II office in

Atlanta and the rest of the team is made up of three additional Region II inspectors and one inspector

from NRC headquarters in Rockville, Maryland.

The AIT will review the event and assess the plant operators’ performance as well as the plant

equipment involved. The inspection team will also review Honeywell’s procedures, the company’s

response to the events and any investigations or reviews by the company. The AIT will conduct an exit

meeting to announce the preliminary results of the inspection at a time to be announced later and a

final publicly-available report will be issued within 30 days of the inspection.

In addition to the AIT inspection, the NRC has issued a Confirmatory Action Letter to

Honeywell to confirm that the company has shut down uranium hexafluoride operations, initiated its

own investigation and will discuss with the NRC both the results of that investigation and proposed

corrective actions prior to restarting the processes involved in the incident.

The issuance of the Confirmatory Action Letter does not preclude the NRC from taking

additional steps, including enforcement actions, for any violations of NRC requirements that may be

identified during the AIT inspection or any subsequent inspections.

 ###
EXHIBIT 107 

Case 1:20-cv-22945-RNS Document 285-108 Entered on FLSD Docket 04/25/2022 Page 1 of

5
Case 1:20-cv-22945-RNS Document 285-108 Entered on FLSD Docket 04/25/2022 Page 2 of

5
Case 1:20-cv-22945-RNS Document 285-108 Entered on FLSD Docket 04/25/2022 Page 3 of

5
Case 1:20-cv-22945-RNS Document 285-108 Entered on FLSD Docket 04/25/2022 Page 4 of

5
Case 1:20-cv-22945-RNS Document 285-108 Entered on FLSD Docket 04/25/2022 Page 5 of

5
I 

108TH CONGRESS 

1ST SESSION H. R. 1567

To amend the Immigration and Nationality Act to deny citizenship at birth 

to children born in the United States of parents who are not citizens 

or permanent resident aliens. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 2, 2003

Mr. DEAL of Georgia introduced the following bill; which was referred to the 

Committee on the Judiciary 

A BILL

To amend the Immigration and Nationality Act to deny 

citizenship at birth to children born in the United States 

of parents who are not citizens or permanent resident 

aliens.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Citizenship Reform 

5 Act of 2003’’.
2

•HR 1567 IH 

1 SEC. 2. PURPOSE. 

2 It is the purpose of this Act to deny automatic citi3 zenship at birth to children born in the United States to 

4 parents who are not citizens or permanent resident aliens. 

5 SEC. 3. CITIZENSHIP AT BIRTH FOR CHILDREN OF NON-CIT6 IZEN, NON-PERMANENT RESIDENT ALIENS. 

7 (a) IN GENERAL.—Section 101 of the Immigration 

8 and Nationality Act (8 U.S.C. 1101) is amended by insert9 ing after subsection (c) the following new subsection: 

10 ‘‘(d) For purposes of section 301(a), a person born 

11 in the United States shall be considered as ‘subject to the 

12 jurisdiction of the United States’ if—

13 ‘‘(1) the child was born in wedlock in the 

14 United States to a parent either of whom is (A) a 

15 citizen or national of the United States, or (B) an 

16 alien who is lawfully admitted for permanent resi17 dence and maintains his or her residence (as defined 

18 in subsection (a)(33)) in the United States; or 

19 ‘‘(2) the child was born out of wedlock in the 

20 United States to a mother who is (A) a citizen or 

21 national of the United States, or (B) an alien who 

22 is lawfully admitted for permanent residence and 

23 maintains her residence in the United States. 

24 For purposes of this subsection, a child is considered to 

25 be ‘born in wedlock’ only if both parents are married to 
3

•HR 1567 IH 

1 each other and parents are not considered to be married 

2 if such marriage is only a common law marriage.’’. 

3 (b) CONFORMING AMENDMENT.—Section 301 of 

4 such Act (8 U.S.C. 1401) is amended by inserting ‘‘(as 

5 defined in section 101(d))’’ after ‘‘subject to the jurisdic6 tion thereof’’. 

7 (c) EFFECTIVE DATE.—The amendments made by 

8 this section shall apply to aliens born on or after the date 

9 of the enactment of this Act.

Æ
NRC NEWS

 U.S. NUCLEAR REGULATORY COMMISSION

 801 Warrenville Road

 Lisle IL 60532

 Web Site: http://www.nrc.gov 

No. III-02-042 (revised) July 11, 2002

CONTACT: Jan Strasma (630) 829-9663 E-mail: opa3@nrc.gov

Viktoria Mitlyng (630) 829-9662 

 

CORRECTED RELEASE: FIRST MEETING AT 2 P.M. INSTEAD OF 3 P.M. 

NRC OVERSIGHT PANEL TO HOLD TWO MEETINGS IN OAK HARBOR, OHIO,

ON DAVIS-BESSE REACTOR VESSEL HEAD DAMAGE

The Nuclear Regulatory Commission staff will hold two meetings on Tuesday, July 16, in

Oak Harbor, Ohio, to review the status of activities at the Davis-Besse Nuclear Power Station as a

result of the corrosion damage to the reactor vessel head. The plant, which has been shut down

since February 15, is operated by FirstEnergy Nuclear Operating Company.

Both meetings will be at the Oak Harbor High School Auditorium, 11661 West State Route

163, in Oak Harbor.

The first meeting will be at 2 p.m. when the NRC oversight panel, set up to coordinate the

agency’s activities associated with the corrosion damage to the reactor vessel head, meets with

utility officials to discuss the plans for replacement of the reactor vessel head and other activities

under the utility’s return-to-service plan. The public is invited to observe the business portion of the

meeting and will have an opportunity to make comments and ask questions of the NRC staff before

the meeting is adjourned.

The second meeting will be at 7 p.m. to update the public on NRC's activities related to the

reactor vessel head degradation. The public will be encouraged to ask questions and make

comments. 

Transcripts will be prepared of both meetings and posted on the NRC’s web site.

The NRC oversight panel, created on April 29, includes NRC management and staff from its

Region III office in Lisle, Illinois, the NRC Headquarters office in Rockville, Maryland, and the

NRC Resident Inspector Office at the Davis-Besse site.

Documents on the Davis-Besse corrosion issue, including meeting transcripts and further

details on NRC’s oversight panel activities, are posted on the NRC’s web site at:

http://www.nrc.gov/reactors/operating/ops-experience/vessel-head-degradation.html.

# # #
Return
      to
      Main Document




Exhibit
      32.2




Certification
        Pursuant to 18 U.S.C. Section 1350 As Adopted Pursuant to Section 906 of
        the
        Sarbanes-Oxley Act of 2002
  In
        connection with the Annual Report of Mexoro Minerals Limited (the "Company)
        on
        Form 10-KSB, for the fiscal year ended February 28, 2006, as filed with the
        United States Securities and Exchange Commission, on the date hereof (the
        "Report"), the undersigned, in the capacities and on the date indicated below,
        hereby certifies, pursuant
        to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350,
        that
        to his knowledge:
  (1)
        The
        Report fully complies with the requirements of Section 13(a) or 15(d) of
        the
        Securities Exchange Act of 1934, as amended; and
  (2)
        The
        information contained in the Report fairly presents, in all material respects,
        the financial condition and results of operations of the Company.
   Date: May
                30, 2006
              /s/Tracy
                MooreTracy MooreChief
                Financial Officer
#### The People of the State of New York ex rel. Belle Grament against Free Synagogue Child Adoption Committee et al.

Present — Glennon, Dore, Callahan, Van Voorhis and Shientag, JJ. [194 Misc. 332.]
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-392]
 ACTION: Notice of application.
 DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 14, 2019. Such persons may also file a written request for a hearing on the application on or before January 14, 2019.
 ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.


SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on October 10, 2018, Mylan Pharmaceuticals Inc., 2898 Manufacturers Road, Greensboro, North Carolina 27406-4600 applied to be registered as an importer of the following basic class of controlled substance: Controlled substance
Drug code
ScheduleNabilone
7379
II
 The company plans to import the FDA approved drug product in finished dosage form for distribution to its customers. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Dated: December 3, 2018. John J. Martin, Assistant Administrator.


[FR Doc. 2018-27036 Filed 12-12-18; 8:45 am] BILLING CODE 4410-09-P
### §1930. Applicable pay rate upon appointment

#### (a) In general

Notwithstanding any other provision of law, the rate of basic pay payable to an individual upon appointment to a position with the Capitol Police shall be at a rate within the minimum and maximum pay rates applicable to the position.

#### (b) Effective date

This section shall apply to fiscal year 2003 and each fiscal year thereafter.

(Pub. L. 108–7, div. H, title I, §1008, Feb. 20, 2003, 117 Stat. 359.)

#### **Editorial Notes**

#### Codification

Section is from the Legislative Branch Appropriations Act, 2003, which is div. H of Pub. L. 108–7.